Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Key findings Within six months of starting GLP-1 therapy, the rate of hypotensive events increased from 8.7% to 10.2% The increased risk remained significant at 12 months, with hypotensive events rising from 13.6% to 14.3% Adults age 65 and older accounted for 53% of hypotensive events despite representing 37% of the study population Patients with Type 2 diabetes made up 75% of those experiencing hypotensive episodes but only 63% of the overall cohort In secondary analyses, the scientists found that weight loss alone did not explain the increased risk, suggesting other mechanisms of action may be at play Below is a Q&A with study senior author Dr
But the most surprising development in obesity pharmacology is from Amgen: MariTide, a drug that targets the GIP receptor in the opposite direction of everyone else
Finally, Kojic acid reduces the formation of excess melanin and lightens pigmentation
Choose whole food carbohydrate sources over processed options whenever possible
